Company Filing History:
Years Active: 2019-2021
Title: Charles Samuel Umbaugh: Innovator in Anti-Cancer Research
Introduction
Charles Samuel Umbaugh is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of anti-cancer research, particularly through his innovative approaches to targeting specific receptors involved in cancer progression. With a total of 2 patents, Umbaugh's work is paving the way for potential clinical applications in cancer treatment.
Latest Patents
Umbaugh's latest patents include a dock derived compound against the laminin receptor (37 LR) and its uses. This invention describes an in silico screening method that generated compounds targeting the laminin receptor 37LR. The anti-cancer functions of these compounds have been tested in prostate cancer cell lines. A group of derivatives based on the hit compound from the in silico screening has been synthesized and tested, showing improved IC values that could have relevant clinical use for prostate cancer or osteoarthritis.
Career Highlights
Charles Samuel Umbaugh is associated with the Purdue Research Foundation, where he continues to advance his research in cancer therapeutics. His work is characterized by a strong focus on innovative methodologies that enhance the efficacy of cancer treatments.
Collaborations
Umbaugh has collaborated with notable colleagues, including Marxa L Figueiredo and Herman O Sintim. These collaborations have contributed to the depth and breadth of his research efforts.
Conclusion
Charles Samuel Umbaugh is a distinguished inventor whose work in anti-cancer research is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.